High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements
Context:Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a fraction of benign thyroid nodules, besides papillary thyroid carcinomas, and it might therefore influence their growth.Objective:The aim of...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 96; no. 6; pp. E916 - E919 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Oxford University Press
01.06.2011
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-972X 1945-7197 1945-7197 |
DOI | 10.1210/jc.2010-1599 |
Cover
Abstract | Context:Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a fraction of benign thyroid nodules, besides papillary thyroid carcinomas, and it might therefore influence their growth.Objective:The aim of the present work was to evaluate whether RET/PTC in benign thyroid nodules associates with a different nodular growth rate.Study Design:In this prospective multicentric study, 125 subjects with benign nodules were included. RET rearrangements were analyzed in cytology samples; clinical and ultrasonographic nodule characteristics were assessed at the start and at the end of the study.Results:
RET/PTC was present in 19 nodules. The difference between the mean baseline nodular volume of the RET/PTC− and RET/PTC+ nodules was not significant. After 36 months of follow-up, the RET/PTC+ group (n = 16) reached a volume higher than the RET/PTC− group (n = 90) (5.04 ± 2.67 vs. 3.04 ± 2.26 ml; P = 0.0028). We calculated the monthly change of nodule volumes as a percentage of baseline. After a mean follow-up of 36.6 months, the monthly volume increase of nodules bearing a RET rearrangement was 4.3-fold that of nodules with wild-type RET (1.83 ± 1.2 vs. 0.43 ± 1.0% of baseline volume; P < 0.0001).Conclusions:Benign thyroid nodules bearing RET rearrangements grow more rapidly than those with wild-type RET. Searching for RET rearrangements in benign thyroid nodules might be useful to the clinician in choosing the more appropriate and timely therapeutic option. |
---|---|
AbstractList | Context:Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a fraction of benign thyroid nodules, besides papillary thyroid carcinomas, and it might therefore influence their growth.Objective:The aim of the present work was to evaluate whether RET/PTC in benign thyroid nodules associates with a different nodular growth rate.Study Design:In this prospective multicentric study, 125 subjects with benign nodules were included. RET rearrangements were analyzed in cytology samples; clinical and ultrasonographic nodule characteristics were assessed at the start and at the end of the study.Results:
RET/PTC was present in 19 nodules. The difference between the mean baseline nodular volume of the RET/PTC− and RET/PTC+ nodules was not significant. After 36 months of follow-up, the RET/PTC+ group (n = 16) reached a volume higher than the RET/PTC− group (n = 90) (5.04 ± 2.67 vs. 3.04 ± 2.26 ml; P = 0.0028). We calculated the monthly change of nodule volumes as a percentage of baseline. After a mean follow-up of 36.6 months, the monthly volume increase of nodules bearing a RET rearrangement was 4.3-fold that of nodules with wild-type RET (1.83 ± 1.2 vs. 0.43 ± 1.0% of baseline volume; P < 0.0001).Conclusions:Benign thyroid nodules bearing RET rearrangements grow more rapidly than those with wild-type RET. Searching for RET rearrangements in benign thyroid nodules might be useful to the clinician in choosing the more appropriate and timely therapeutic option. Context:Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a fraction of benign thyroid nodules, besides papillary thyroid carcinomas, and it might therefore influence their growth.Objective:The aim of the present work was to evaluate whether RET/PTC in benign thyroid nodules associates with a different nodular growth rate.Study Design:In this prospective multicentric study, 125 subjects with benign nodules were included. RET rearrangements were analyzed in cytology samples; clinical and ultrasonographic nodule characteristics were assessed at the start and at the end of the study.Results: RET/PTC was present in 19 nodules. The difference between the mean baseline nodular volume of the RET/PTC− and RET/PTC+ nodules was not significant. After 36 months of follow-up, the RET/PTC+ group (n = 16) reached a volume higher than the RET/PTC− group (n = 90) (5.04 ± 2.67 vs. 3.04 ± 2.26 ml; P = 0.0028). We calculated the monthly change of nodule volumes as a percentage of baseline. After a mean follow-up of 36.6 months, the monthly volume increase of nodules bearing a RET rearrangement was 4.3-fold that of nodules with wild-type RET (1.83 ± 1.2 vs. 0.43 ± 1.0% of baseline volume; P < 0.0001).Conclusions:Benign thyroid nodules bearing RET rearrangements grow more rapidly than those with wild-type RET. Searching for RET rearrangements in benign thyroid nodules might be useful to the clinician in choosing the more appropriate and timely therapeutic option. Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a fraction of benign thyroid nodules, besides papillary thyroid carcinomas, and it might therefore influence their growth.CONTEXTBenign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a fraction of benign thyroid nodules, besides papillary thyroid carcinomas, and it might therefore influence their growth.The aim of the present work was to evaluate whether RET/PTC in benign thyroid nodules associates with a different nodular growth rate.OBJECTIVEThe aim of the present work was to evaluate whether RET/PTC in benign thyroid nodules associates with a different nodular growth rate.In this prospective multicentric study, 125 subjects with benign nodules were included. RET rearrangements were analyzed in cytology samples; clinical and ultrasonographic nodule characteristics were assessed at the start and at the end of the study.STUDY DESIGNIn this prospective multicentric study, 125 subjects with benign nodules were included. RET rearrangements were analyzed in cytology samples; clinical and ultrasonographic nodule characteristics were assessed at the start and at the end of the study.RET/PTC was present in 19 nodules. The difference between the mean baseline nodular volume of the RET/PTC- and RET/PTC+ nodules was not significant. After 36 months of follow-up, the RET/PTC+ group (n = 16) reached a volume higher than the RET/PTC- group (n = 90) (5.04 ± 2.67 vs. 3.04 ± 2.26 ml; P = 0.0028). We calculated the monthly change of nodule volumes as a percentage of baseline. After a mean follow-up of 36.6 months, the monthly volume increase of nodules bearing a RET rearrangement was 4.3-fold that of nodules with wild-type RET (1.83 ± 1.2 vs. 0.43 ± 1.0% of baseline volume; P < 0.0001).RESULTSRET/PTC was present in 19 nodules. The difference between the mean baseline nodular volume of the RET/PTC- and RET/PTC+ nodules was not significant. After 36 months of follow-up, the RET/PTC+ group (n = 16) reached a volume higher than the RET/PTC- group (n = 90) (5.04 ± 2.67 vs. 3.04 ± 2.26 ml; P = 0.0028). We calculated the monthly change of nodule volumes as a percentage of baseline. After a mean follow-up of 36.6 months, the monthly volume increase of nodules bearing a RET rearrangement was 4.3-fold that of nodules with wild-type RET (1.83 ± 1.2 vs. 0.43 ± 1.0% of baseline volume; P < 0.0001).Benign thyroid nodules bearing RET rearrangements grow more rapidly than those with wild-type RET. Searching for RET rearrangements in benign thyroid nodules might be useful to the clinician in choosing the more appropriate and timely therapeutic option.CONCLUSIONSBenign thyroid nodules bearing RET rearrangements grow more rapidly than those with wild-type RET. Searching for RET rearrangements in benign thyroid nodules might be useful to the clinician in choosing the more appropriate and timely therapeutic option. Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a fraction of benign thyroid nodules, besides papillary thyroid carcinomas, and it might therefore influence their growth. The aim of the present work was to evaluate whether RET/PTC in benign thyroid nodules associates with a different nodular growth rate. In this prospective multicentric study, 125 subjects with benign nodules were included. RET rearrangements were analyzed in cytology samples; clinical and ultrasonographic nodule characteristics were assessed at the start and at the end of the study. RET/PTC was present in 19 nodules. The difference between the mean baseline nodular volume of the RET/PTC- and RET/PTC+ nodules was not significant. After 36 months of follow-up, the RET/PTC+ group (n = 16) reached a volume higher than the RET/PTC- group (n = 90) (5.04 ± 2.67 vs. 3.04 ± 2.26 ml; P = 0.0028). We calculated the monthly change of nodule volumes as a percentage of baseline. After a mean follow-up of 36.6 months, the monthly volume increase of nodules bearing a RET rearrangement was 4.3-fold that of nodules with wild-type RET (1.83 ± 1.2 vs. 0.43 ± 1.0% of baseline volume; P < 0.0001). Benign thyroid nodules bearing RET rearrangements grow more rapidly than those with wild-type RET. Searching for RET rearrangements in benign thyroid nodules might be useful to the clinician in choosing the more appropriate and timely therapeutic option. |
Author | Marotta, Vincenzo Motta, Manuela Fenzi, Gianfranco Rossi, Guido Vitale, Mario Campanile, Elisabetta Deandrea, Maurilio Guerra, Anna Sapio, Maria Rosaria Formisano, Raffaele Limone, Paolo Piero |
Author_xml | – sequence: 1 givenname: Maria Rosaria surname: Sapio fullname: Sapio, Maria Rosaria organization: 1Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (M.R.S., A.G., V.M., E.C., R.F., G.F., M.V.), Università Federico II, 80131 Naples, Italy – sequence: 2 givenname: Anna surname: Guerra fullname: Guerra, Anna organization: 1Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (M.R.S., A.G., V.M., E.C., R.F., G.F., M.V.), Università Federico II, 80131 Naples, Italy – sequence: 3 givenname: Vincenzo surname: Marotta fullname: Marotta, Vincenzo organization: 1Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (M.R.S., A.G., V.M., E.C., R.F., G.F., M.V.), Università Federico II, 80131 Naples, Italy – sequence: 4 givenname: Elisabetta surname: Campanile fullname: Campanile, Elisabetta organization: 1Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (M.R.S., A.G., V.M., E.C., R.F., G.F., M.V.), Università Federico II, 80131 Naples, Italy – sequence: 5 givenname: Raffaele surname: Formisano fullname: Formisano, Raffaele organization: 1Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (M.R.S., A.G., V.M., E.C., R.F., G.F., M.V.), Università Federico II, 80131 Naples, Italy – sequence: 6 givenname: Maurilio surname: Deandrea fullname: Deandrea, Maurilio organization: 2Struttura complessa di Endocrinologia (M.D., P.P.L.), Presidio Ospedaliero “Umberto I,” Ordine Mauriziano, 10128 Torino, Italy – sequence: 7 givenname: Manuela surname: Motta fullname: Motta, Manuela organization: 3Struttura complessa di Anatomia Patologica (M.M.), Presidio Ospedaliero “Umberto I,” Ordine Mauriziano, 10128 Torino, Italy – sequence: 8 givenname: Paolo Piero surname: Limone fullname: Limone, Paolo Piero organization: 2Struttura complessa di Endocrinologia (M.D., P.P.L.), Presidio Ospedaliero “Umberto I,” Ordine Mauriziano, 10128 Torino, Italy – sequence: 9 givenname: Gianfranco surname: Fenzi fullname: Fenzi, Gianfranco organization: 1Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (M.R.S., A.G., V.M., E.C., R.F., G.F., M.V.), Università Federico II, 80131 Naples, Italy – sequence: 10 givenname: Guido surname: Rossi fullname: Rossi, Guido organization: 4Dipartimento di Biologia e Patologia Cellulare e Molecolare (G.R.), Università Federico II, 80131 Naples, Italy – sequence: 11 givenname: Mario surname: Vitale fullname: Vitale, Mario email: mavitale@unina.it organization: 1Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (M.R.S., A.G., V.M., E.C., R.F., G.F., M.V.), Università Federico II, 80131 Naples, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21411555$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1LAzEQhoMotn7cPMuCBy-uZjab3c1RS_0AUSkVvIU0nW1TtklNdhH_vam2l4KnmXl5ZpiZ94jsW2eRkDOg15ABvVno64wCTYELsUf6IHKeliDKfdKnNINUlNlHjxyFsKAU8pyzQ9LLIAfgnPfJ06OZzZMH777aeTJSLSauTu7QmplNxvNv78w0eXHTrsEQZeWNnSWj4fjmbTxIRrH2ys5wibYNJ-SgVk3A0008Ju_3w_HgMX1-fXga3D6nmnHaphqhniIvaxpLoRBFUWsUvIiyYJoLBRkvSohSXQrUWnBFGeQxqWo6ydkxufybu_Lus8PQyqUJGptGWXRdkFVRsYoWLIvkxQ65cJ23cTnJoMhzVkBVRup8Q3WTJU7lypul8t9y-6MIZH-A9i4Ej7XUplWtcbb1yjQSqFwbIRdaro2QayNi09VO03buP_jmKNet_iN_HWY_3buSrQ |
CitedBy_id | crossref_primary_10_1186_1471_2482_13_S2_S49 crossref_primary_10_1016_j_beem_2014_01_011 crossref_primary_10_1530_EJE_11_0499 crossref_primary_10_1002_cncr_29044 crossref_primary_10_1186_1471_2482_13_S2_S44 crossref_primary_10_1016_j_ecl_2018_10_003 crossref_primary_10_1186_1471_2482_13_S2_S41 crossref_primary_10_1089_thy_2012_0614 crossref_primary_10_1007_s15006_013_2404_9 crossref_primary_10_1530_EJE_14_0930 crossref_primary_10_2217_bmm_13_67 crossref_primary_10_1016_j_ijsu_2014_05_045 crossref_primary_10_1016_j_ijsu_2014_05_043 crossref_primary_10_1038_s41598_019_44931_8 crossref_primary_10_1007_s12020_012_9843_4 crossref_primary_10_1089_thy_2013_0610 crossref_primary_10_1007_s00060_014_0002_9 crossref_primary_10_1089_thy_2013_0235 crossref_primary_10_1089_thy_2013_0278 crossref_primary_10_1111_cen_13591 crossref_primary_10_1038_nrc3431 crossref_primary_10_1016_j_ctrv_2015_06_002 crossref_primary_10_1186_s13044_023_00161_9 crossref_primary_10_1038_nrendo_2011_142 crossref_primary_10_3390_cells10051082 crossref_primary_10_1007_s40618_014_0128_z crossref_primary_10_1016_j_critrevonc_2013_12_007 crossref_primary_10_1186_1471_2482_13_S2_S37 crossref_primary_10_1210_jc_2011_3106 crossref_primary_10_1016_j_jasc_2015_01_001 crossref_primary_10_1007_s15015_014_0001_0 crossref_primary_10_1080_14737140_2016_1238764 crossref_primary_10_1530_JOE_17_0266 crossref_primary_10_1586_14789450_2015_1062369 crossref_primary_10_2174_0929867327666200214125712 crossref_primary_10_1089_thy_2014_0338 crossref_primary_10_1089_thy_2017_0318 crossref_primary_10_1155_2023_7951942 crossref_primary_10_4158_EP12304_OR crossref_primary_10_1111_cen_12875 crossref_primary_10_1530_ERC_16_0372 crossref_primary_10_1038_nrendo_2017_24 crossref_primary_10_3390_ijms18040806 crossref_primary_10_1007_s12020_015_0773_9 crossref_primary_10_1111_cen_12194 |
Cites_doi | 10.1128/MCB.21.13.4177-4187.2001 10.1507/endocrj.K10E-229 10.1210/er.2002-0016 10.1038/sj.onc.1207790 10.1111/j.1365-2265.1992.tb02898.x 10.1210/jc.2003-031870 10.1128/MCB.16.5.2151 10.1016/S1074-7613(00)80165-X 10.1210/jc.2001-011762 10.1210/jcem.83.3.4615 10.1146/annurev.immunol.19.1.397 10.7326/0003-4819-122-1-199501010-00001 10.1038/sj.onc.1200206 10.1038/labinvest.3780377 10.1007/BF03350907 10.1172/JCI200522758 |
ContentType | Journal Article |
Copyright | Copyright © 2011 by The Endocrine Society 2011 Copyright © 2011 by The Endocrine Society |
Copyright_xml | – notice: Copyright © 2011 by The Endocrine Society 2011 – notice: Copyright © 2011 by The Endocrine Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM H94 K9. 7X8 |
DOI | 10.1210/jc.2010-1599 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | E919 |
ExternalDocumentID | 21411555 10_1210_jc_2010_1599 10.1210/jc.2010-1599 |
Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GroupedDBID | --- -~X .55 .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL ABBLC ABDFA ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABVGC ABWST ABXVV ACGFO ACGFS ACPRK ACUTJ ACYHN ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AETBJ AEWNT AFCHL AFFNX AFFZL AFGWE AFOFC AFRAH AFXAL AGINJ AGKRT AGQXC AGUTN AHMBA AHMMS AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BSWAC BTRTY C45 CDBKE CS3 D-I DAKXR DIK E3Z EBS EJD EMOBN ENERS F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 HZ~ H~9 KBUDW KOP KQ8 KSI KSN L7B M5~ MHKGH MJL N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G REU ROX ROZ TEORI TJX TLC TR2 TWZ VVN W8F WOQ X7M YBU YFH YHG YOC YSK ZY1 ~02 ~H1 AAYXX ABXZS ADNBA AEMQT AEOTA AFYAG AGORE ALXQX CITATION NU- .GJ 3O- 7X7 88E 8FI 8FJ AAJQQ AAKAS AAPGJ AAQQT AAUQX AAWDT AAYJJ ABDPE ABUWG ACFRR ACVCV ACZBC ADMTO ADZCM AERZD AFFQV AFKRA AGMDO AI. AJDVS APJGH AQDSO AQKUS AVNTJ BENPR BPHCQ BVXVI CCPQU CGR CUY CVF ECM EIF EIHJH FEDTE FYUFA HMCUK HVGLF IAO IHR INH ITC J5H M1P MBLQV N4W NPM OBFPC PHGZT PQQKQ PROAC PSQYO TMA UKHRP VH1 WHG X52 ZGI ZXP 7QP 7T5 7TM AEHZK H94 K9. 7X8 |
ID | FETCH-LOGICAL-c350t-ce1fde57f03509aee96fce9561fd93c59a125671e95f79ecc95a0314cc98f0b43 |
ISSN | 0021-972X 1945-7197 |
IngestDate | Sun Sep 28 16:07:35 EDT 2025 Fri Sep 19 20:53:53 EDT 2025 Thu Apr 03 07:00:45 EDT 2025 Tue Jul 01 00:49:52 EDT 2025 Thu Apr 24 23:05:29 EDT 2025 Fri Feb 07 10:35:23 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c350t-ce1fde57f03509aee96fce9561fd93c59a125671e95f79ecc95a0314cc98f0b43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 21411555 |
PQID | 3164436187 |
PQPubID | 2046206 |
ParticipantIDs | proquest_miscellaneous_868380632 proquest_journals_3164436187 pubmed_primary_21411555 crossref_citationtrail_10_1210_jc_2010_1599 crossref_primary_10_1210_jc_2010_1599 oup_primary_10_1210_jc_2010-1599 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20110601 2011-06-01 2011-Jun |
PublicationDateYYYYMMDD | 2011-06-01 |
PublicationDate_xml | – month: 06 year: 2011 text: 20110601 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2011 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Melillo (2020071616354365000_B14) 2005; 115 Unger (2020071616354365000_B10) 2004; 89 La Rosa (2020071616354365000_B19) 1995; 122 Mellado (2020071616354365000_B13) 2001; 19 Hegedüs (2020071616354365000_B1) 2003; 24 Borrello (2020071616354365000_B3) 1996; 16 Ishizaka (2020071616354365000_B4) 1991; 6 Santoro (2020071616354365000_B2) 1996; 12 Castellone (2020071616354365000_B15) 2004; 23 Elisei (2020071616354365000_B5) 2001; 86 Melillo (2020071616354365000_B9) 2001; 21 Costante (2020071616354365000_B16) 2004; 27 Zlotnik (2020071616354365000_B12) 2000; 12 Reverter (2020071616354365000_B20) 1992; 36 (2020071616354365000_B7) 2002 Corvi (2020071616354365000_B11) 2001; 81 Marotta (2020071616354365000_B8) 2010; 57 Castro (2020071616354365000_B17) 2002; 87 Bounacer (2020071616354365000_B6) 1997; 15 Papini (2020071616354365000_B18) 1998; 83 |
References_xml | – volume: 21 start-page: 4177 year: 2001 ident: 2020071616354365000_B9 article-title: Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. publication-title: Mol Cell Biol doi: 10.1128/MCB.21.13.4177-4187.2001 – volume: 57 start-page: 1081 year: 2010 ident: 2020071616354365000_B8 article-title: Growing thyroid nodules with benign histology and RET rearrangement. publication-title: Endocr J doi: 10.1507/endocrj.K10E-229 – volume: 86 start-page: 3211 year: 2001 ident: 2020071616354365000_B5 article-title: RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. publication-title: J Clin Endocrinol Metab – volume: 24 start-page: 102 year: 2003 ident: 2020071616354365000_B1 article-title: Management of simple nodular goiter: current status and future perspectives. publication-title: Endocr Rev doi: 10.1210/er.2002-0016 – volume: 23 start-page: 5958 year: 2004 ident: 2020071616354365000_B15 article-title: Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas. publication-title: Oncogene doi: 10.1038/sj.onc.1207790 – volume: 36 start-page: 25 year: 1992 ident: 2020071616354365000_B20 article-title: Suppressive therapy with levothyroxine for solitary thyroid nodules. publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.1992.tb02898.x – start-page: 7 volume-title: Fine-needle aspiration cytology (FNAC). Guidelines for the management of thyroid cancer in adults year: 2002 ident: 2020071616354365000_B7 – volume: 89 start-page: 4272 year: 2004 ident: 2020071616354365000_B10 article-title: Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031870 – volume: 12 start-page: 1821 year: 1996 ident: 2020071616354365000_B2 article-title: Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. publication-title: Oncogene – volume: 16 start-page: 2151 year: 1996 ident: 2020071616354365000_B3 article-title: The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. publication-title: Mol Cell Biol doi: 10.1128/MCB.16.5.2151 – volume: 12 start-page: 121 year: 2000 ident: 2020071616354365000_B12 article-title: Chemokines: a new classification system and their role in immunity. publication-title: Immunity doi: 10.1016/S1074-7613(00)80165-X – volume: 87 start-page: 4154 year: 2002 ident: 2020071616354365000_B17 article-title: Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2001-011762 – volume: 83 start-page: 780 year: 1998 ident: 2020071616354365000_B18 article-title: Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.83.3.4615 – volume: 19 start-page: 397 year: 2001 ident: 2020071616354365000_B13 article-title: Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.19.1.397 – volume: 122 start-page: 1 year: 1995 ident: 2020071616354365000_B19 article-title: Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. publication-title: Ann Intern Med doi: 10.7326/0003-4819-122-1-199501010-00001 – volume: 15 start-page: 1263 year: 1997 ident: 2020071616354365000_B6 article-title: High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. publication-title: Oncogene doi: 10.1038/sj.onc.1200206 – volume: 81 start-page: 1639 year: 2001 ident: 2020071616354365000_B11 article-title: Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization. publication-title: Lab Invest doi: 10.1038/labinvest.3780377 – volume: 27 start-page: 31 year: 2004 ident: 2020071616354365000_B16 article-title: Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women. publication-title: J Endocrinol Invest doi: 10.1007/BF03350907 – volume: 6 start-page: 1667 year: 1991 ident: 2020071616354365000_B4 article-title: Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. publication-title: Oncogene – volume: 115 start-page: 1068 year: 2005 ident: 2020071616354365000_B14 article-title: The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. publication-title: J Clin Invest doi: 10.1172/JCI200522758 |
SSID | ssj0014453 |
Score | 2.2882686 |
Snippet | Context:Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a... Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a... |
SourceID | proquest pubmed crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | E916 |
SubjectTerms | Adult Aged Benign Blotting, Southern Cytology Female Gene Rearrangement Growth rate Humans Male Middle Aged Nodules Oncogene Proteins, Fusion - genetics Papillary thyroid carcinoma Prospective Studies Proto-Oncogene Proteins c-ret - genetics Ret protein Thyroid Thyroid gland Thyroid Nodule - diagnostic imaging Thyroid Nodule - genetics Thyroid Nodule - pathology Ultrasonography |
Title | High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21411555 https://www.proquest.com/docview/3164436187 https://www.proquest.com/docview/868380632 |
Volume | 96 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals Online customDbUrl: eissn: 1945-7197 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: DIK dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1945-7197 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: GX1 dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAviDuFgfwAT1VgaWwnfuRStIE2oalDe4sc29E6dc6UpkLsL_EnOad20lR03F6i1HWT9Jwv52KfCyEveWzB7kxNVDBjIpB-SVTEhkXSGp2BRhJqlRR2eCT2T9inU346GPzoRS0tm-K1vtqaV_I_XIUx4Ctmyf4DZ7uLwgCcA3_hCByG41_xGIM0cPXoW3M2OlZ-w_-dddhqc3r2va5mZnRUmeXcLmBY-Ui7yRTu92WKhFV1jakFF205p9ZIRej0Kkp0yZPWmQqEjFuXbbqwDYBo3pYhxJUadTmrQhLQTI2Oq4Xygcw-ymdp69qv5DrXjcLUqvFW7NcZgNBdVf2tEeVmPuZ5MseCwLZpVH-tIu7FVP0uB7IvnzFgJF01WAft5EWyZDxKYx_F28ps3wU3YLMvgCcyFj1lDh_lVkUBni4qCr0K7ovAppNrhdiFKW6feIPcHKdCYLuMDwefuy0rxkLJ0_AXQpYFpkj1f71h_2zkVP7i2qxMnOldcif4JvStB9o9MrDuPrl1GKIvHpADxBv1eKOIN1qV1OONBrzRgDca8EYBb28AbXQTbQ_JycfJ9P1-FFpxRDrhe02kbVway9MSN6KlslaKUltMii6NTDSXCgxlkcYwVKYSxILkChsjwElW7hUseUR2XOXsE0JToUuuWaLAV2CqyLIyEbHgcs-WqbFMDsmoJVCuQ516bJcyz9FfBXLm5zpHcuZIziF51c2-9PVZrplHgdbXTYn8lN2WEXl4yRZ5EoPDAA-YpXCF7msQwbivppytlos8E1mSgak_HpLHnn_dfcYxA5eL86d_vv0zcnv9yuySnaZe2udg8DbFixXQfgJmZKbq |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+Growth+Rate+of+Benign+Thyroid+Nodules+Bearing+RET%2FPTC+Rearrangements&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Sapio%2C+Maria+Rosaria&rft.au=Guerra%2C+Anna&rft.au=Marotta%2C+Vincenzo&rft.au=Campanile%2C+Elisabetta&rft.date=2011-06-01&rft.pub=Oxford+University+Press&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=96&rft.issue=6&rft.spage=E916&rft.epage=E919&rft_id=info:doi/10.1210%2Fjc.2010-1599&rft.externalDocID=10.1210%2Fjc.2010-1599 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |